| P6099 | clinical trial phase | phase IV clinical trial | Q42825046 |
| P17 | country | United States of America | Q30 |
| P582 | end time | 2010-07-22 | |
| P4135 | maximum age | 21 | |
| P2899 | minimum age | 10 | |
| P1132 | number of participants | 0 | |
| P6153 | research site | National Institutes of Health | Q390551 |
| P859 | sponsor | Eunice Kennedy Shriver National Institute of Child Health and Human Development | Q5409765 |
| P580 | start time | 2007-07-18 | |
| P8363 | study type | interventional study | Q78089383 |
| P1476 | title | Use of the GnRH Agonist Leuprolide Acetate (Lupron(Registered Trademark)) to Preserve Ovarian Function in Women Undergoing Chemotherapy | |